相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions
Shuji Fukuda et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
GLP-1 Agonists in Type 1 Diabetes Mellitus
Kristin M. Janzen et al.
ANNALS OF PHARMACOTHERAPY (2016)
Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer's Disease
LiMei Qin et al.
CURRENT ALZHEIMER RESEARCH (2016)
The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
Dilan Athauda et al.
DRUG DISCOVERY TODAY (2016)
Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model
Liqin Qi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm
Eugenio Barone et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Michael Gejl et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice
Paula L. McClean et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling
Yuta Yoshino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway
Yi Bao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline
V. A. Gault et al.
DIABETES OBESITY & METABOLISM (2015)
Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats
Volkan Solmaz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Sitagliptin attenuated brain damage and cognitive impairment in mice with chronic cerebral hypo-perfusion through suppressing oxidative stress and inflammatory reaction
Tzu-Hsien Tsai et al.
JOURNAL OF HYPERTENSION (2015)
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes
Weijie Xu et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2015)
Hippocampal insulin resistance and cognitive dysfunction
Geert Jan Biessels et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal neurons
Oliver Takach et al.
NEUROBIOLOGY OF AGING (2015)
A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis
Sylvia Ortega-Martinez
FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)
Aberrant insulin signaling in Alzheimer's disease: current knowledge
Gaurav Bedse et al.
FRONTIERS IN NEUROSCIENCE (2015)
Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
Simon C. Cork et al.
MOLECULAR METABOLISM (2015)
Preservation of the Blood Brain Barrier and Cortical Neuronal Tissue by Liraglutide, a Long Acting Glucagon-Like-1 Analogue, after Experimental Traumatic Brain Injury
Jakob Hakon et al.
PLOS ONE (2015)
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
Sergio T. Ferreira et al.
ALZHEIMERS & DEMENTIA (2014)
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease
Konrad Talbot et al.
ALZHEIMERS & DEMENTIA (2014)
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
D. Allan Butterfield et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK3β Pathway in Streptozotocin-Induced Alzheimer Rat Model
Chong Gao et al.
BRAIN PATHOLOGY (2014)
Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
Fernanda G. De Felice et al.
DIABETES (2014)
Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
Laurie L. Baggio et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
Christian Hoelscher
JOURNAL OF ENDOCRINOLOGY (2014)
Glucagon-Like Peptide-1 Protects Synaptic and Learning Functions From Neuroinflammation in Rodents
Takashi Iwai et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Kathleen M. Dungan et al.
LANCET (2014)
DEMENTIA IN THE DEVELOPING WORLD: RISK, IMPACT, AND PREVENTION
Emiliano Albanese et al.
NEUROBIOLOGY OF AGING (2014)
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice
Rachael Lennox et al.
NEUROPHARMACOLOGY (2014)
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism
Nadia M. Krasner et al.
PLOS ONE (2014)
Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
Geert Jan Biessels et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function
Cassandra Koole et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer's β-Amyloid Oligomers in Mice and Monkeys
Mychael V. Lourenco et al.
CELL METABOLISM (2013)
The gut hormone glucagon-like peptide-1 produced in brain: is this physiologically relevant?
Stefan Trapp et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
History of Medically Treated Diabetes and Risk of Alzheimer Disease in a Nationwide Case-Control Study
Anna-Maija Tolppanen et al.
DIABETES CARE (2013)
DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption
Noppamas Pipatpiboon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain
Vadivel Parthsarathy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice
David Tweedie et al.
EXPERIMENTAL NEUROLOGY (2013)
DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats
Hiranya Pintana et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Insulin in the Brain: Sources, Localization and Functions
Rasoul Ghasemi et al.
MOLECULAR NEUROBIOLOGY (2013)
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer's Disease
Caitriona M. Long-Smith et al.
NEUROMOLECULAR MEDICINE (2013)
Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
Jayasankar Kosaraju et al.
NEUROPHARMACOLOGY (2013)
Role of central glucagon-like peptide-1 in stress regulation
Sriparna Ghosal et al.
PHYSIOLOGY & BEHAVIOR (2013)
Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model
Vadivel Parthsarathy et al.
PLOS ONE (2013)
Releasing the brake: restoring fast axonal transport in neurodegenerative disorders
Maria-Victoria Hinckelmann et al.
TRENDS IN CELL BIOLOGY (2013)
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
M. Bomba et al.
CELL DEATH & DISEASE (2013)
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4
Song Chen et al.
AGE (2012)
The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
Aya Shiraki et al.
ATHEROSCLEROSIS (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
(Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains
Lin Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
G. Cheng et al.
INTERNAL MEDICINE JOURNAL (2012)
Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation
Cassandra Koole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage
Jack Hou et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers
Theresa R. Bomfim et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Neuroprotective actions of Glucagon-like peptide-1 in differentiated human neuroprogenitor cells
Kalpana Velmurugan et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Glucagon-Like Peptide-1 Cleavage Product GLP-1(9-36) Amide Rescues Synaptic Plasticity and Memory Deficits in Alzheimer's Disease Model Mice
Tao Ma et al.
JOURNAL OF NEUROSCIENCE (2012)
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
Simon Gengler et al.
NEUROBIOLOGY OF AGING (2012)
Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures
Dong-Hou Kim et al.
NEUROBIOLOGY OF DISEASE (2012)
Axonal transport and neurodegenerative disease: Can we see the elephant?
Lawrence S. B. Goldstein
PROGRESS IN NEUROBIOLOGY (2012)
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
Thomas Karagiannis et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
Michael A. Nauck
AMERICAN JOURNAL OF MEDICINE (2011)
Glucagon-like peptide 1 and the brain: Central actions-central sources?
Stefan Trapp et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2011)
Snapin Mediates Incretin Action and Augments Glucose-Dependent Insulin Secretion
Woo-Jin Song et al.
CELL METABOLISM (2011)
Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation
Mireille Belanger et al.
CELL METABOLISM (2011)
Neuroprotective properties of GLP-1: theoretical and practical applications
Jens Juul Holst et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. F. Deacon
DIABETES OBESITY & METABOLISM (2011)
The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
Ruben Isacson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Serotonin syndrome in an orthopaedic patient secondary to linezolid therapy for MRSA infection
M. McClean et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Novel GLP-1 Mimetics Developed To Treat Type 2 Diabetes Promote Progenitor Cell Proliferation in the Brain
A. Hamilton et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
GLP-1 and energy balance: an integrated model of short-term and long-term control
Jason G. Barrera et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes
Eva Tomas et al.
REGULATORY PEPTIDES (2011)
Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation
Daisuke Yabe et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2011)
Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders
Louis A. Profenno et al.
BIOLOGICAL PSYCHIATRY (2010)
Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model
Paola Luciani et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Building Genetic Scores to Predict Risk of Complex Diseases in Humans: Is It Possible?
Simin Liu et al.
DIABETES (2010)
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease
Paula L. McClean et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice
Michele D'Amico et al.
EXPERIMENTAL GERONTOLOGY (2010)
GLP-1 Receptor Stimulation Reduces Amyloid-beta Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
Yazhou Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer's disease?
Christian Hoelscher et al.
NEUROBIOLOGY OF AGING (2010)
Insulin metabolism and the risk of Alzheimer disease The Rotterdam Study
E. M. C. Schrijvers et al.
NEUROLOGY (2010)
Val8-GLUCAGON-LIKE PEPTIDE-1 PROTECTS AGAINST Aβ1-40-INDUCED IMPAIRMENT OF HIPPOCAMPAL LATE-PHASE LONG-TERM POTENTIATION AND SPATIAL LEARNING IN RATS
X. H. Wang et al.
NEUROSCIENCE (2010)
Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus
Hua Li et al.
NEUROSCIENCE LETTERS (2010)
Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides
Niels Vrang et al.
PROGRESS IN NEUROBIOLOGY (2010)
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
Talib Abbas et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Tissue Distribution of the Novel DPP-4 Inhibitor BI 1356 is Dominated by Saturable Binding to its Target in Rats
Holger Fuchs et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections
Aberra Fura et al.
DRUG METABOLISM AND DISPOSITION (2009)
Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons
Denise D. Belsham et al.
FASEB JOURNAL (2009)
Nutritional regulation of glucagon-like peptide-1 secretion
Gwen Tolhurst et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
GLUCAGON-LIKE PEPTIDE-1 (GLP-1) PROTECTS AGAINST METHYLGLYOXAL-INDUCED PC12 CELL APOPTOSIS THROUGH THE PI3K/Akt/mTOR/GCLc/REDOX SIGNALING PATHWAY
R. Kimura et al.
NEUROSCIENCE (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
Fernanda G. De Felice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
J. -F. Gautier et al.
DIABETES & METABOLISM (2008)
GLP-1 receptor signaling:: effects on pancreatic β-cell proliferation and survival
J. Buteau
DIABETES & METABOLISM (2008)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Low, but Physiological, Concentration of GLP-1 Stimulates Insulin Secretion Independent of the cAMP-Dependent Protein Kinase Pathway
Makoto Shigeto et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway
Jianhui Liu et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
GLP-1 receptor expression in human tumors and human normal tissues:: Potential for in vivo targeting
Meike Koerner et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
Food-derived advanced glycation end products (AGEs): A novel therapeutic target for various disorders
Sho-ichi Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Neurotrophic property of geniposide for inducing the neuronal differentiation of PC12 cells
Jianhui Liu et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2006)
Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
Takashi Iwai et al.
NEUROSCIENCE RESEARCH (2006)
Investigational treatments for Type 2 diabetes mellitus:: exenatide and liraglutide
Claudio Gonzalez et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic β-cell function after 3-week daily administration in obese diabetic (ob/ob) mice
Brian D. Green et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Structural and functional changes in human insulin induced by methylglyoxal
Xuming Jia et al.
FASEB JOURNAL (2006)
Transcription factor Fox01 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass
J Buteau et al.
DIABETES (2006)
Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease:: review and hypothesis
WQ Qiu et al.
NEUROBIOLOGY OF AGING (2006)
Molecular control of cell cycle progression in the pancreatic beta-cell
Irene Cozar-Castellano et al.
ENDOCRINE REVIEWS (2006)
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage
C Knauf et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Glucagon-expressing neurons within the retina regulate the proliferation of neural progenitors in the circumferential marginal zone of the avian eye
AJ Fischer et al.
JOURNAL OF NEUROSCIENCE (2005)
Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site
CW Hay et al.
JOURNAL OF ENDOCRINOLOGY (2005)
The role of insulin receptor signaling in the brain
L Plum et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
β-cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1
YH Li et al.
DIABETES (2005)
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes
B Ahrén et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease
GS Watson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
LL Nielsen et al.
REGULATORY PEPTIDES (2004)
Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
SM Grundy et al.
CIRCULATION (2004)
Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell
GG Holz
DIABETES (2004)
Hyperinsulinemia and risk of Alzheimer disease
JA Luchsinger et al.
NEUROLOGY (2004)
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets
L Farilla et al.
ENDOCRINOLOGY (2003)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
CAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
US Jhala et al.
GENES & DEVELOPMENT (2003)
Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
T Perry et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis
DJ Drucker
MOLECULAR ENDOCRINOLOGY (2003)
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Gαs and Gαi/Gαo activation
M Hällbrink et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2001)
Insulin resistance: definition and consequences
HE Lebovitz
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
分享论文
